NCT03767348Phase 2Active not recruiting

Study of RP1 Monotherapy and RP1 in Combination With Nivolumab (IGNYTE)

Study sponsor: Replimune, Inc.

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2028-06Estimated
Enrollment · participants340Estimated
Source updated2026-02-13Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 1 field changed

Primary completion date changed

Before: Dec 2025. After: Jun 2028.

Check registry source

· 1 field changed

Recruitment status changed

Before: Recruiting. After: Active not recruiting.

Check registry source

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview